{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:47:43Z","timestamp":1782190063824,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,11]],"date-time":"2027-02-11T00:00:00Z","timestamp":1802304000000},"content-version":"am","delay-in-days":286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010067","name":"Government of Arag\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1R16GM149396"],"award-info":[{"award-number":["1R16GM149396"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000181","name":"Air Force Office of Scientific Research","doi-asserted-by":"publisher","award":["FA9550-20-1-0158"],"award-info":[{"award-number":["FA9550-20-1-0158"]}],"id":[{"id":"10.13039\/100000181","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["DICRIDG-22-1012253-01-DICRIDG"],"award-info":[{"award-number":["DICRIDG-22-1012253-01-DICRIDG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015616","name":"Gray Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021895","name":"Brooklyn College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2024-155563NB-I00"],"award-info":[{"award-number":["PID2024-155563NB-I00"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Inorganic Biochemistry"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jinorgbio.2026.113254","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:31:05Z","timestamp":1770507065000},"page":"113254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancer"],"prefix":"10.1016","volume":"278","author":[{"given":"Marayke","family":"Mayrata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Lopez-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban P.","family":"Urriolabeitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"McCarrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Manu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier E.","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle C.","family":"Neary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Contel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinorgbio.2026.113254_bb0005","author":"International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbpa.2022.102155","article-title":"Highlighting the roles of transition metals and speciation in chemical biology","volume":"69","author":"Kostenkova","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jtemb.2010.01.006","article-title":"Platinum speciation used for elucidating activation or inhibition of Pt-containing anticancer drugs","volume":"24","author":"Michalke","year":"2010","journal-title":"J. Trace Elem. Med. Biol."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0020","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1039\/D0SC04082G","article-title":"Metallodrugs are unique: opportunities and challenges of discovery and development","volume":"11","author":"Anthony","year":"2020","journal-title":"Chem. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1021\/acscentsci.3c01340","article-title":"Metals in Cancer research: beyond platinum Metallodrugs","volume":"10","author":"Casini","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.chempr.2019.10.013","article-title":"Classification of metal-based drugs according to their mechanisms of action","volume":"6","author":"Boros","year":"2020","journal-title":"Chem"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0035","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-024-01889-y","article-title":"Current advance of nanotechnology in diagnosis and treatment for malignant tumors","volume":"9","author":"Wang","year":"2024","journal-title":"Sig. Transduct. Target. Ther."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/cancers14030622","article-title":"Targeted delivery methods for anticancer drugs","volume":"14","author":"Veselov","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116644","article-title":"Metallodrugs: synthesis, mechanism of action and nanoencapsulation for targeted chemotherapy","volume":"231","author":"Rodrigues","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0050","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3390\/cancers13040670","article-title":"Recent advancements in stimuli-responsive drug delivery platforms for active and passive cancer targeting","volume":"13","author":"Rahim","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0055","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1021\/jacs.2c09820","article-title":"Encapsulation of gold-based anticancer agents in protease-degradable peptide Nanofilaments enhances their potency","volume":"145","author":"Marciano","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0060","series-title":"Pharmaceuticals (Basel)","first-page":"729","article-title":"Game changers: blockbuster small-molecule drugs approved by the FDA in <pubYear>2024<\/pubYear&gt","volume":"18","author":"Wang","year":"2025"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ddtec.2015.08.002","article-title":"Speciation of precious metal anticancer complexes by NMR spectroscopy","volume":"16","author":"Zou","year":"2015","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0070","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.3390\/molecules24122240","article-title":"NMR-based metabolomics in metal-based drug research","volume":"24","author":"De Castro","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0075","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cbpa.2021.03.003","article-title":"NMR spectroscopy to study the fate of metallodrugs in cells","volume":"61","author":"Arnesano","year":"2021","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0080","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1039\/D3DT04138G","article-title":"Organometallic Ru(II), Rh(III) and re(I) complexes of sterane-based bidentate ligands: synthesis, solution speciation, interaction with biomolecules and anticancer activity","volume":"53","author":"Pivarcsik","year":"2024","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0085","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1021\/jm5012337","article-title":"In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds: a potential chemotherapeutic agent for triple-negative breast cancer","volume":"57","author":"Frik","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0090","series-title":"Arene ruthenium(II) derivatives containing iminophosphorane ligands and their use in cancer therapy, US Patent 9,555,049 B2","author":"Contel","year":"2017"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0095","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/om100997x","article-title":"Cycloruthenated complexes from iminophosphoranes: synthesis, structure, and reactivity with internal alkynes","volume":"30","author":"Aguilar","year":"2011","journal-title":"Organometallics"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0100","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1002\/cmdc.202100325","article-title":"Investigation of the effects and mechanisms of anticancer action of a Ru(II)-arene iminophosphorane compound in triple-negative breast cancer cells","volume":"21","author":"Nayeem","year":"2021","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0105","doi-asserted-by":"crossref","first-page":"19152","DOI":"10.1021\/acs.inorgchem.1c02929","article-title":"Intracellular localization studies of the luminescent analogue of an anticancer ruthenium iminophosphorane with high efficacy in a triple-negative breast cancer mouse model","volume":"60","author":"Miachin","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0110","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/acsptsci.4c00020","article-title":"Insights into mechanisms and promising triple-negative breast cancer therapeutic potential for a water-soluble ruthenium compound","volume":"7","author":"Nayeem","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0115","doi-asserted-by":"crossref","first-page":"7974","DOI":"10.1021\/acs.inorgchem.1c00507","article-title":"Piano-stool ruthenium(II) complexes with delayed cytotoxic activity: origin of the lag time","volume":"60","author":"Rafols","year":"2021","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0120","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-14-0247","article-title":"Say no to DMSO: dimethyl sulfoxide inactivates cisplatin, carboplatin, and other platinum complexes","volume":"74","author":"Hall","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0125","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/antiox13050582","article-title":"Dimethyl sulfoxide (DMSO) as a potential source of interference in research related to sulfur metabolism\u2014a preliminary study","volume":"9","author":"Kaczor-Kami\u0144ska","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/9780470132524.ch16","article-title":"(\u03b76-Hexamethylbenzene)ruthenium complexes","volume":"21","author":"Bennett","year":"1982","journal-title":"Inorg. Synth."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0135","first-page":"1233","article-title":"Structure of a second monoclinic polymorph of triphenylphosphine oxide","volume":"C43","author":"Speck","year":"1987","journal-title":"Acta Cryst."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0140","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/BF01160986","article-title":"Crystal structure of triphenylphosphine oxide","volume":"22","author":"Al-Farhan","year":"1992","journal-title":"J. Cryst. Spectrosc."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0145","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1021\/ic50021a046","article-title":"Solvent effects on the phosphorus-31 chemical shift in triphenylphosphine oxide","volume":"3","author":"Maciel","year":"1964","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0150","doi-asserted-by":"crossref","first-page":"8717","DOI":"10.1021\/acs.jpcc.6b01140","article-title":"Effect of hydrogen bonding to water on the 31P chemical shift tensor of phenyl- and trialkylphosphine oxides and \u03b1-amino phosphonates","volume":"120","author":"Begimova","year":"2016","journal-title":"J. Phys. Chem. C"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0155","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1021\/jm900731j","article-title":"Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes","volume":"52","author":"van Rijt","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0160","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/ic401529u","article-title":"Rhodium, iridium, and ruthenium half-sandwich picolinamide complexes as anticancer agents","volume":"53","author":"Almodares","year":"2014","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0165","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1039\/b918902e","article-title":"Synthesis, molecular structure and evaluation of new organometallic ruthenium anticancer agents","author":"Camm","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0170","doi-asserted-by":"crossref","unstructured":"L.R. Falvello, M.M. Garc\u00eda, I. L\u00e1zaro, R. Navarro, E.P. Urriolabeitia, Different coordinating behavior of the imino-phosphoranes Ph3P=NC(O)CH2Cl and Ph3P=NC(O)-2-NC5H4 towards MII complexes (M = Pd, Pt), doi:https:\/\/doi.org\/10.1039\/A807066K, New J. Chem.","DOI":"10.1039\/a807066k"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0175","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.2174\/138527207781662519","article-title":"15N NMR spectroscopy in structural analysis: an update (2001\u20132005)","volume":"11","author":"Marek","year":"2007","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0180","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jinorgbio.2005.07.009","article-title":"Synthesis, spectral study and cytotoxicity of platinum(II) complexes with 2,9-disubstituted-6-benzylaminopurines","volume":"99","author":"Malo\u0148","year":"2005","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122093","article-title":"SEC hyphenated to a multielement-specific detector unravels the degradation pathway of a bimetallic anticancer complex in human plasma","volume":"1145","author":"Sarpong-Kumankomah","year":"2020","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0190","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1021\/jo00210a027","article-title":"Synthesis of N-acyl-, N-sulfonyl-, and N-phosphinylphospha(PV)azenes by a redox-condensation reaction using amides, triphenylphosphine, and diethyl azodicarboxylate","volume":"50","author":"Bittner","year":"1985","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0195","series-title":"SHELXTL: An Integrated System for Solving, Refining, and Displaying Crystal Structures from Diffraction Data, University of G\u00f6ttingen, G\u00f6ttingen, Federal Republic of Germany","author":"Sheldrick","year":"1981"},{"key":"10.1016\/j.jinorgbio.2026.113254_bb0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. Sect. C Struct. Chem."}],"container-title":["Journal of Inorganic Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0162013426000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T04:09:15Z","timestamp":1782187755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0162013426000437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"alternative-id":["S0162013426000437"],"URL":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113254","relation":{},"ISSN":["0162-0134"],"issn-type":[{"value":"0162-0134","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Inorganic Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinorgbio.2026.113254","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113254"}}